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Abstract
Pre-treatment selection or censoring (‘selection on treatment’) can occur when
two treatment levels are compared ignoring the third option of neither treatment, in
‘censoring by death’ settings where treatment is only defined for those who survive
long enough to receive it, or in general in studies where the treatment is only defined
for a subset of the population. Unfortunately, the standard instrumental variable (IV)
estimand is not defined in the presence of such selection, so we consider estimating
a new survivor-complier causal effect. Although this effect is generally not identi-
fied under standard IV assumptions, it is possible to construct sharp bounds. We
derive these bounds and give a corresponding data-driven sensitivity analysis, along
with nonparametric yet efficient estimation methods. Importantly, our approach al-
lows for high-dimensional confounding adjustment, and valid inference even after
employing machine learning. Incorporating covariates can tighten bounds dramati-
cally, especially when they are strong predictors of the selection process. We apply
the methods in a UK cohort study of critical care patients to examine the mortality
effects of prompt admission to the intensive care unit, using ICU bed availability as
an instrument.
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1 Introduction
1.1 Time to ICU Admission
In UK hospitals, nurses can call for a critical care assessment to judge whether deteriorating
patients on general hospital wards should be transferred to the intensive care unit (ICU)
for a higher level of critical care. When a critical care assessment is ordered, staff from
the ICU assess whether the patient would improve under ICU care. Patients can at this
time be admitted to the ICU, but they may not be directly transferred to the ICU. If ICU
bed space is limited, the patient is admitted but often must wait to be transferred to the
ICU. Clinical guidelines in the UK indicate that a patient should be transferred to the ICU
within four hours (The Faculty of Intensive Care Medicine & Intensive Care Society 2013).
One open clinical question is whether delayed admission to the ICU is harmful. More
specifically: does admission to the ICU in less than four hours contribute to decreased
mortality? This question is made more complex by two factors. First, time to admission is
undefined for patients that are not admitted to the ICU at the time of assessment. That
is, we do not observe a time to transfer for any patient that is not admitted. As such,
important information is censored for part of the study population. Second, the mix of
patients makes naive comparisons of mortality rates for patients quickly transferred to the
ICU to those with delayed admission deceiving. It is very likely that patients with short
wait times tend to be sicker than patients with delayed transfer. If that is the case, prompt
transfer to the ICU would be associated with higher not lower mortality rates. However,
this association arises because of the characteristics of those patients who are promptly
transferred, rather than because of their prompt ICU care.
A carefully designed randomized experiment could overcome these difficulties. If we were
to randomize all admitted to patients to different wait times for admission, we could identify
the causal effect among a specific sub-population. However, ethical constraints make an
experiment of this type infeasible. Alternatively we might seek to find a natural experiment.
A natural experiment is some naturally occurring circumstance that results in haphazard
if not as-if random assignment of the treatment. An instrument is one type of natural
experiment. In our case, an instrumental variable (IV) would give a haphazard nudge
towards being admitted to the ICU, but would only affect outcomes indirectly through
ICU admission and by no other means.
However, standard IV methods only identify the effect of being admitted to the ICU,
while we seek to identify the causal effect of delayed transfer to the ICU. Since wait times
are undefined or censored for those patients not admitted to the ICU, standard IV meth-
ods fail. Therefore we develop methods for estimating the effect of delayed transfer, among
the principal stratum of patients who would always be admitted to the ICU regardless of
bed availability. Unfortunately this effect is not point-identified under standard IV assump-
tions, but we can nonetheless construct sharp covariate-adjusted bounds and corresponding
flexible estimation methods. Combining IV methods with partial identification approaches
has a long history, to which our work contributes (Manski 1990; Manski 1996; Balke &
Pearl 1997; Kitagawa 2009; Siddique 2013; Mealli & Pacini 2013). Next, we describe the
data in greater detail.
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1.2 Data & Descriptive Statistics
The data we use is from a prospective cohort study of general ward patients who were
referred to critical care in the ICU in 48 National Health Service (NHS) hospitals between 1
November 2010 and 31 December 2011 (the SPOTlight study) (Harris et al. 2015). The data
record information for every general ward patient that was assessed for possible admission to
the ICU including the decision to admit a patient to ICU care and the time from assessment
to actual transfer into the ICU. Importantly, data collection also included a measure of
ICU occupancy rates at the specific time of the patient assessment. This measure of ICU
bed availability at time of assessment serves as an instrument in our study. The data
collection also included a number of baseline covariates such as age, septic diagnosis (0/1),
peri-arrest (0/1), and measures of physiology. These measures of physiology include the
Intensive Care National Audit & Research Centre (ICNARC) physiology score, the NHS
National Early Warning Score (NEWS) which measures whether respiratory rate, oxygen
saturations, temperature, systolic blood pressure, pulse rate, a level of consciousness vary
from the norm, and the Sequential Organ Failure Assessment (SOFA) score which ranges
from 0 to 24, with higher scores indicating a greater degree of organ failure. The data also
record the patient’s existing level of care at assessment and recommended level of care after
assessment using the UK Critical Care Minimum Dataset (CCMDS) levels of care. These
levels are 0 and 1 for normal ward care, 2 for care within a high dependency unit, and 3
for care with intensive care unit. Finally, the data include indicators for whether it was
the weekend, out of hours (between 7 PM and 7 AM), or the months from November to
February. The primary endpoint is 28-day mortality.
In total, the data contain information on 15158 patients on general hospital wards that
were assessed for admission to the ICU. From this total, we exclude 2141 patients due
to the presence of a treatment limitation order which excluded the possibility of transfer
to the ICU. We further exclude six additional patients that have missing data on the
availability of beds in the ICU at the time of assessment, giving us a study population of
13011 patients that were assessed for possible transfer to the ICU. Of these 13011 patients,
27% were admitted to the ICU with a median time to transfer of 2 hours. However, 8.3%
of patients that were initially admitted were never transferred to the ICU. Figure 1 plots
the distribution of wait times for transfer to the ICU, where it is clear that while many
patients are transferred within four hours, the time for many patients significantly exceeds
that threshold.
1.3 An Instrumental Variables Approach
As we noted above, we address the question of ICU wait times within an IV framework.
Specifically, we use ICU bed availability as an instrument for admission to the ICU. That
is, if many beds are available at the time of assessment, this should serve as a haphazard
encouragement for ICU admittance. Under a set of causal identification assumptions, IVs
allow for the identification of causal effects subject to a form of unobserved confounding
that is likely in our application (Angrist et al. 1996). See Keele et al. (2016) for an in-depth
study of bed availability as an instrument for ICU admission.
Any use of IVs requires careful assessment of whether the identification assumptions
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Figure 1: Distribution of ICU wait times. Vertical red line indicates four hour mark. Three
observations with wait times in excess of 50 hours removed from the data.
are plausible. However, standard application of IV methods in our application will fail
due to selection bias. As we noted above, the waiting time for transfer to the ICU is only
observed when a patient is admitted to the ICU. Thus for patients that are assessed but
not admitted to critical care, wait times and the counterfactual mortality outcome under
wait times are undefined. In our application, selection arises through this censoring, since
the treatment may be undefined due to selection that occurs prior to treatment.
Some recent papers haved considered settings where the outcome can be undefined but
treatment is always observed, i.e., it is assumed that the selection or censoring event (e.g.,
death) can only occur after treatment (Imai 2008; Yang & Small 2016). However, this
is substantially different from our application, where the selection is based on treatment
status; as we show, selection on treatment leads to different causal estimands and requires
new methods. More relevant is the work by Swanson et al. (2015) and Ertefaie et al.
(2016), who first discovered and discussed the fundamental selection-on-treatment problem
with IVs. Our work adds to these papers in several critical respects. First, Swanson et al.
(2015) importantly pointed out the problem and discussed the biases of standard IV anal-
yses, but did not present any solutions. Ertefaie et al. (2016) followed with a sensitivity
analysis approach for the same estimand we consider in this paper, but their approach
requires numerous sensitivity parameters, does not yield provably sharp bounds, and does
not accommodate covariates (even low-dimensional). In contrast, our approach can exploit
potentially high-dimensional covariate information to make bounds as sharp as possible
(and weaken identifying assumptions), and otherwise is indexed by only two interpretable
sensitivity parameters. Importantly we use influence function theory to develop nonpara-
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metric estimators that can converge at fast parametric rates, even when based on flexible
machine learning methods; our approach can similarly be extended to other partial iden-
tification problems involving high-dimensional covariates, which we feel is a critical but
understudied area.
This article is organized as follows. In Section 2 we outline notation, define the causal
estimand, and derive identification conditions. In Section 3 we outline a set of sharp
nonparametric bounds for the causal estimand of interest. We also derive a data-driven
sensitivity analysis that uses the bounds to allow for more informative inferences, and
propose new estimators that allow for high-dimensional covariate adjustment. We then
apply the methods in the aforementioned UK cohort study to examine mortality effects of
prompt admission to the ICU. In Section 4 we use simulations to explore the conditions
under which the bounds are most informative. Section 5 concludes.
2 Notation, Causal Estimand, & Identification
2.1 Notation
We suppose we observe an independent and identically distributed sample (O1, ...,On)
from distribution P where O = (X, Z, S,A, Y ) with X denoting covariate information, Z
a binary instrument, S an indicator of the selection event, A a binary treatment that is
only defined when S = 1, and Y some outcome of interest (which may also only be defined
when S = 1). In our example, Z is an indicator of bed availability (with Z = 1 indicating
that there are more than the average number of beds available), and S indicates whether
a patient was accepted for ICU admission. Treatment A = 1 indicates a wait time less
than 4 hours before actually being transferred into the ICU. For all patients not admitted
to the ICU (i.e., with S = 0), wait time until transfer into the ICU is undefined, as are
counterfactual mortality outcomes under different waiting times. In our application, Y is
a binary indicator of death; however all results can also be extended to arbitrary bounded
outcomes.
A directed acyclic graph showing the causal structure is given in Figure 2, with arrows
between variables indicating causal relationships. The graph shows baseline covariates X,
instrument Z, selection event S (the box enclosing S indicates that subsequent variables
are only defined conditional on S = 1), treatment A, and outcome Y , along with any un-
measured confounders U . If only time-ordering is taken into account, then all arrows would
be present (excluding those that allow the future to cause the past); however the relation-
ships underlying the gray dotted arrows are assumed absent by standard IV assumptions,
as discussed in the next subsection.
Although we illustrate the data structure in graphical terms in Figure 2, we use po-
tential outcome notation to formalize assumptions and characterize causal effects (Rubin
1974). Specifically we let (S(z), A(z), Y (z)) denote selection, treatment, and outcome had
the instrument been set to Z = z, and similarly we let (Y (z,a), Y (a)) denote outcomes had
the instrument and/or treatment been set to Z = z and/or A = a. Our goal is to learn
about the distribution of the effect Y (a=1) − Y (a=0), but this contrast only makes sense for
some units in the population, as we will make more explicit in the next subsection.
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Figure 2: Directed acyclic graph showing covariates X, instrument Z, selection event S,
treatment or exposure A, outcome Y , and unmeasured variables U . The exposure A
(and possibly outcome Y ) are only defined when S = 1. Gray dotted arrows indicate
relationships that are assumed absent in a standard instrumental variable analysis.
Finally, we note that selection on treatment can also arise when the goal is to compare
only two levels of a multivalued treatment (Swanson et al. 2015; Ertefaie et al. 2016). In
this setting, S = 1 would indicate that one of the two treatment levels of interest was
received (e.g., statin type), while S = 0 would indicate receipt of an alternative treatment
(e.g., no statins at all); here A would indicate which of the two treatments of interest was
received, and would be undefined when S = 0. This kind of selection bias also occurs
when patients die during follow-up, after encouragement by the instrument but prior to
the measurement of treatment. Then the selection event S is survival, so that S = 0 means
a patient died; in this case subsequent treatment and outcomes are undefined, and it often
does not make sense to consider what values might have been had the patient survived
(Tchetgen Tchetgen 2014).
2.2 Causal Estimand
In this subsection we make explicit our target of inference, i.e., formally define which causal
contrast we aim to identify and estimate. Since the treatment of interest A is only defined
when S = 1 (e.g., how long a patient waits to be transferred to the ICU is only defined
for patients who are admitted to be transferred to the ICU), and since setting S = 1 for
all patients might not be a meaningful counterfactual (e.g., some patients might be too
healthy or too sick to ever be admitted to the ICU), it is reasonable to restrict inference
to the subgroup of patients who would always be selected, regardless of instrument value,
i.e., those patients with
S(z=1) = S(z=0) = 1
with probability one. These are the patients who would always be admitted to the ICU,
regardless of bed availability. Note that this is really the only subgroup for which we can
discuss treatment effects, since treatment is not defined if S = 0. This is an example of a
principal stratum since it is defined based on a cross-classification of joint counterfactuals
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(Frangakis & Rubin 2002). This particular kind of principal stratum commonly arises in
censoring-by-death settings (Zhang & Rubin 2003; Tchetgen Tchetgen 2014) where coun-
terfactuals are defined based on treatment rather than instrument values, as well as in
vaccine effect studies where interest centers on effects among sicker patients who would
always be infected regardless of treatment status (Hudgens et al. 2003).
One could also argue that the distribution of Y (a=1) − Y (a=0) should be explored in a
further refined subgroup, in particular only within those always-selected or survivor patients
who would actually respond to encouragement by the instrument, i.e., those with
A(z=1) > A(z=0).
These units are commonly termed compliers in the IV literature (Angrist et al. 1996).
Under appropriate assumptions, these are patients whose wait time would depend on bed
availability. That is, these patients would only wait less than 4 hours if there were beds
availabile at the time of critical care assessment. There is an ongoing debate about the
merits of exploring causal effects within such subgroups (Imbens 2014; Swanson & Herna´n
2014). In this paper we take a pluralistic perspective, viewing complier effects as mean-
ingful but only one piece of the puzzle, which can be combined with inference about other
subgroups. Our focus on them is driven by both subject matter concerns in our ICU
application and because they are a popular target of inference in IV studies.
As such, in our analysis we focus on the causal effect among those always-selected
patients who would respond to IV encouragement, i.e.,
ψ = E
(
Y (a=1) − Y (a=0)
∣∣∣ S(z=1) = S(z=0) = 1, A(z=1) > A(z=0)).
We call this parameter the survivor-complier average treatment effect, or SCATE. It rep-
resents the mortality risk difference due to waiting less than four hours (A = 1) versus
more than four hours (A = 0), among patients who would always be admitted to the ICU
but whose wait time would depend on bed availability. Negative values of this esitmand
indicate that shorter wait times reduce mortality in this subgroup.
2.3 Identification Conditions
Next, we summarize standard IV assumptions that we rely on in this paper, and discuss
why the SCATE ψ is not point-identified under them. We also give an expression for ψ
that will be important for constructing bounds and interpretable sensitivity analyses. Since
ψ is expressed in terms of only partially observed potential outcomes, we will need causal
assumptions to be able to learn anything about it. Instead of tailoring our assumptions so
as to ensure point identification (i.e., so that ψ can be uniquely expressed as a functional
of the observed data distribution P), we instead see what we can learn about the SCATE
ψ under standard IV assumptions. Specifically we assume the following:
Assumption 1 (Consistency).
S = ZS(z=1) + (1− Z)S(z=0),
A = ZA(z=1) + (1− Z)A(z=0) (if S = 1),
Y = ZY (z=1) + (1− Z)Y (z=0) (if S = 1).
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Assumption 2 (Positivity). 0 < P(Z = 1 | X) < 1.
Assumption 3 (Instrumentation). P(A(z=1) > A(z=0), S(z=1) = S(z=0) = 1) ≥  > 0.
Assumption 4 (Unconfoundedness). Z ⊥⊥ (S(z), A(z), Y (z)) | X for z = 0, 1.
Assumption 5 (Exclusion). E(Y (z,a) − Y (a) | S(z=1) = S(z=0) = 1) = 0 for z = 0, 1.
Assumption 6 (Monotonicity Restriction).
P(S(z=1) ≥ S(z=0)) = 1,
P(A(z=1) ≥ A(z=0) | S(z=1) = S(z=0) = 1) = 1.
Analogs of Assumptions 1–6 are all standard in the IV literature, although monotonicity
is sometimes replaced by effect homogeneity or no-interaction assumptions (Robins 1994;
Herna´n & Robins 2006; Tan 2010). Under consistency, we assume that any variation in
how patients receive care in the ICU corresponds to the same potential outcomes. The
positivity assumption implies that, regardless of covariate value, each patient has some
chance of receiving each instrument value. Under instrumentation, the survivor-complier
subgroup must be nonempty. We can partly assess this assumption from the data. When
the number of ICU beds available is higher than average, patients are admitted to the
ICU 61% of the time, and they waited less than four hours 42% of the time. When
the number of beds available was lower than average, patients were admitted to the ICU
53% of the time but only 34% waited less than four hours. Unconfoundedness says that
(within strata of observed covariates) the instrument is as good as randomized, since it is
conditionally independent of potential outcomes. In the data, bed availability in general
tells us little about patient characteristics or risk severity. If the exclusion restriction
holds among the always-selected, the instrument has no direct effect on outcomes and
thus can only affect outcomes through the treatment. We judge the exclusion restriction
plausible, since bed occupancy in the ICU is measured when the patient is assessed for
ICU admission. To violate the exclusion restriction, there would have to be some aspects
of bed availability at the time of assessment that contributes directly to patient mortality.
Finally, the monotonicity assumption implies that there are no units who would always
do the opposite of what the instrument encourages them to do, either with respect to
selection or treatment; in other words this assumption rules out the possibility of ‘defiers’.
The monotonicity assumption would be violated if the hospital staff assessing patients for
ICU admission encouraged prompt transfer to the ICU when there were few beds available,
and discouraged prompt transfer when there were many beds available. Such behavior
seems unlikely. See (Angrist et al. 1996; Herna´n & Robins 2006) for a more in-depth
discussion of Assumptions 1–6, including ways in which they could be violated.
With (Z, S,A) all binary, there are nine possible principal strata, three of which are
ruled out by monotonicity; this is illustrated in Table 1. Monotonicity implies that any
patient who would be admitted with few beds available would also be admitted with more
beds available, and among those patients who would always be admitted to the ICU, having
more beds available would not delay transfer times relative to having fewer beds available.
Thus, in this application, monotonicity is probably a reasonable assumption.
Under Assumptions 1–6 the SCATE parameter ψ is not identified. The following propo-
sition states this, and is proved in the Appendix (with all other results).
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Table 1: Principal strata defined by (Z, S,A) and strata excluded by assumption. Strata
excluded by monotonicity are shaded in gray. Primary stratum of interest is in row seven.
S(z=0) S(z=1) A(z=0) A(z=1)
0 0 · ·
0 1 · 0
0 1 · 1
1 0 0 ·
1 0 1 ·
1 1 0 0
1 1 0 1
1 1 1 0
1 1 1 1
Proposition 1. The survivor-complier effect ψ is not identified under Assumptions 1–
6, i.e., there exist data-generating processes with ψ1 6= ψ2 that imply the same observed
probability distribution P for (X, Z, S,A, Y ).
In other words, because the same observed data distribution P can be consistent with
different values of ψ, even knowing P without error (e.g., with infinite sample size) is not
enough to learn the true value of ψ with certainty. As pointed out for example by Yang &
Small (2016) and Ertefaie et al. (2016) in related identification problems, this is essentially
a result of the fact that the conditional distribution of Y given (Z, S,A) is a mixture of
potential outcome distributions from different principal strata.
Although the SCATE ψ is not point-identified, we show in the next section that it is still
possible to construct informative bounds and sensitivity analyses. Before that, though, we
first define a fundamental expression for the ψ, indicating how it relates to the proportion
of survivor-compliers and an intention-to-treat effect. Again, proofs of all results are given
in the Appendix.
Proposition 2. Under Assumptions 1, 3, 5, and 6, we can write the SCATE as
ψ = (β/α)P(S(z=1) = S(z=0) = 1)
where
α = P(S(z=1) = S(z=0) = 1, A(z=1) > A(z=0))
is the survivor-complier proportion, and
β = E(Y (z=1) − Y (z=0) | S(z=1) = S(z=0) = 1)
is the survivor intention-to-treat effect (i.e., effect of Z among always-selected).
The parameter α is the survivor-complier proportion, which is a measure of the strength
of the instrument, and is also important since it measures the size of the non-identified
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population in which the effect is being estimated. In our application, this is the proportion
of patients that wait less than four hours to gain access to the ICU because they were
encouraged by bed availability in the ICU. The intention-to-treat effect, β, is the change
in mortality caused by bed availability among the sub-population that would always be
admitted to the ICU in less than four hours. The term β, in addition to providing an
upper-bound on complier effects, does not require monotonicity of treatment (though in
our setting its bounds will require monotonicity of selection). The quantities (α, β) may
be of interest in their own right, but they also play a crucial role in constructing bounds
and sensitivity analyses for the SCATE ψ, since they are the unidentified parts of ψ.
3 Bounds, Sensitivity Analysis, & Estimation
Next, we derive bounds on the SCATE ψ, and we use these bounds to construct optimally
informative and interpretable sensitivity analysis parameters; we then detail flexible yet
efficient estimation methods.
3.1 Bounds
Although the SCATE ψ is not point-identified, we show here that it is possible to construct
potentially informative bounds. Bounds are often used to derive inferences under weaker
conditions than those needed for point identification (Grilli & Mealli 2008; Schwartz et
al. 2012; Zhang et al. 2008). Importantly, our analysis exploits covariate information to
sharpen bounds as much as possible; then we use these worst-case bounds to aid a more
informative sensitivity analysis.
For notational simplicity, we denote
piz(x) = P(Z = z | X = x),
θz(a | x) = P(A = a | X = x, Z = z),
λz(x) = E(S | X = x, Z = z),
µz(x) = E(Y S | X = x, Z = z)
as important nuisance functions that will be used throughout. Note that since A ∈ {0, 1, ·},
we have 1−θz(0 | x) = θz(1 | x)+θz(· | x) where A = · if S = 0. Also, as pointed out earlier,
we focus on the case where Y is binary, although our results equally apply to arbitrary
outcomes as long as they are bounded.
In the next theorem we provide bounds (α`, αu) on the survivor-complier proportion α
and bounds (β`, βu) on the survivor intention-to-treat effect β. We will use these bounds
to construct bounds and a sensitivity analysis for the SCATE ψ.
Theorem 1. Under Assumptions 1–6, the survivor-complier proportion is bounded as
E[{θ0(0 | X)− θ1(0 | X)}+] ≤ α ≤ E{θ1(1 | X)− θ0(1 | X)},
and the survivor intention-to-treat effect is bounded as
E[{µ1(X) + λ0(X)− λ1(X)}+ − µ0(X)]
E{λ0(X)} ≤ β ≤
E[{µ1(X) ∧ λ0(X)} − µ0(X)]
E{λ0(X)} .
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The intuition behind the bound on α is as follows. Under Assumptions 1–6, the quantity
θ1(1 | X)−θ0(1 | X) = P(A(z=1) = 1 | X)−P(A(z=0) = 1 | X) is the difference in proportions
of units exposed to the treatment (less than a 4 hour wait) when encouraged versus not
among units with covariates X. This equals the proportion with covariates X who either are
survivor-compliers or are selection-compliers (S(z=1) > S(z=0)) that take treatment when
encouraged, which is the upper bound on the proportion of survivor-compliers. Averaging
the covariate-specific upper bound gives an upper bound on the marginal proportion of
survivor-compliers. Similar logic shows that θ0(0 | X) − θ1(0 | X) = P(A(z=1) 6= 0 |
X)−P(A(z=0) 6= 0 | X) equals the covariate-specific proportion of survivor-compliers minus
the proportion of selection-compliers that take control when encouraged, which is clearly
a lower bound. Note that when there is no selection (i.e., S = 1 with probability one), the
lower and upper bounds collapse to E(A | X, Z = 1)−E(A | X, Z = 0), which is equivalent
to the denominator of the usual Wald estimator
The bounds on β are a covariate-adjusted version of those previously given by Hudgens
et al. (2003) and Zhang & Rubin (2003), since β is the survivor average causal effect of
encouragement by the IV. As with α, when there is no selection, the bounds on β collapse
to the numerator of the usual Wald estimand given by E(Y | X, Z = 1)−E(Y | X, Z = 0),
since in that case we have λz(X) = 1. In fact the lower bound β` can collapse to a scaled
version of the Wald numerator even in the presence of selection, whenever there is no
differential selection for those encouraged or not, i.e., when P{λ1(X) = λ0(X)} = 1 or
equivalently S ⊥⊥ Z | X.
Using the bounds for α and β, we can construct bounds on the SCATE ψ, since the
other term in the numerator is identified. These bounds are given in the next theorem.
Theorem 2. Let (α`, αu) and (β`, βu) denote the lower and upper bounds for α and β,
respectively, given in Theorem 1. Under Assumptions 1–6, the SCATE is bounded as
β` E{λ0(X)}
(αu − α`)1(β` > 0) + α` ≤ ψ ≤
βu E{λ0(X)}
(α` − αu)1(βu > 0) + αu .
As with the bounds on α and β, the bounds (ψ`, ψu) on the SCATE collapse to the
usual Wald estimator when there is no selection. However, even in the presence of selection,
the bounds operate in a fashion analogous to the Wald estimator. In each case, we have
a ratio estimator based on the bounds for α and β. The numerators are bounds on β,
which is the analog of the intention-to-treat effect, and the denominators are bounds on
α/P(S(z=1) = S(z=0) = 1), which is the proportion of compliers among the survivors. The
correction factor (α`−αu) picks out the appropriate bound on α depending on the sign for
the bound on β. When S ⊥⊥ Z | X, the width of the bounds is completely determined by
the non-identification of the proportion of survivor-compliers α.
While the width of the bounds depends on the use of covariates, not all covariates are
equally useful in narrowing the bounds. Covariates that are strong predictors of selection
S are especially important. In the extreme case where S = g(X) for some g (i.e., covariates
can perfectly predict selection), then the bounds collapse to a single point. A proof of this
fact is given in the Appendix. In intermediate cases, where the covariates for S are good but
not perfect predictors, the bounds can still be much tighter than those not incorporating
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covariates; this is illustrated via simulations in Section 4. These results show how covariates
can be critical to improving the bounds. They should also help guide data collection in
that researchers should focus on covariates that are strong predictors of selection.
Apart from the cases mentioned above where covariates are perfectly predictive, the only
way to achieve point identification of the SCATE ψ is to add stronger assumptions. For
example, if one assumed that the third stratum in Table 1 was empty, i.e., that P(S(z=1) >
S(z=0), A(z=1) = 1 | X) = 0, then α would be identified with its upper bound α = αu.
Conversely, if one assumed the second stratum in Table 1 was empty, i.e., that P(S(z=1) >
S(z=0), A(z=1) = 0 | X) = 0, then α would be identified with its lower bound α = α`.
Since β is a survivor average effect of IV encouragement, it could be identified by adding
assumptions considered by previous authors, such as parametric modeling assumptions
(Zhang et al. 2009), structural assumptions about pre-treatment covariates (Ding et al.
2011), or no unmeasured confounding assumptions given baseline or post-IV covariates
(Tchetgen Tchetgen 2014). In our view, additional identifying assumptions of this type are
likely implausible in the ICU application.
3.2 Sensitivity Analysis
In some cases, the bounds given in Theorem 2 will be sufficiently narrow so as to be
informative and practically meaningful. In other cases, however, they may be wide and
thus unsatisfactory in that they only give a worst-case snapshot of possible SCATE values.
In the latter case, we propose that it is more informative to display all possible values
of ψ as a function of interpretable sensitivity parameters, not just the two most extreme
worst-case possibilities. This is in the same spirit as Ichino et al. (2008), for example, since
the goal is to use the data to inform more specific inferences about ψ.
In our setting, there are two natural sensitivity parameters: the survivor-complier pro-
portion α and the survivor intention-to-treat effect β. We can vary these sensitivity param-
eters by interpolating between their upper and lower bounds given in Theorem 1. Therefore
we consider the parameter
ψ∗(δ) =
{
δ2βu + (1− δ2)β`
δ1αu + (1− δ1)α`
}
E{λ0(X)}
for (δ1, δ2) = δ ∈ [0, 1]2. Note that larger values of δ1 correspond to larger values of α, and
larger values of δ2 correspond to larger values of β, with δ1 = 1 recovering αu and δ1 = 0
recovering α`, and similarly for β. And of course we have ψ` ≤ ψ∗(δ) ≤ ψu for any δ,
where (ψ`, ψu) are the bounds on the SCATE given in Theorem 2. However, consideration
of ψ∗(δ) allows for more nuance than just (ψ`, ψu), since ψ∗(δ) allows us to incorporate prior
knowledge about the sizes of the survivor-complier proportion α or the intention-to-treat
effect β.
Although we index ψ∗(δ) with the parameter δ to simplify notation and theoretical
analysis, in practice (e.g., when plotting results) it will be more useful to index estimates
by the implied values of (α, β), i.e., by α∗ = δ1αu + (1− δ1)α` and β∗ = δ2βu + (1− δ2)β`.
More specifically, we index ψ∗(δ) by δ to reflect the fact that the implied values (α∗, β∗)
are not arbitrarily chosen, but instead depend on the bounds (α`, αu) and (β`, βu) implied
11
by P. This will be important when accounting for uncertainty in estimating ψ∗(δ) due to
the fact that we have estimated the bounds for (α, β).
Note that what we propose is different from a standard sensitivity analysis, which typ-
ically relies on fixed arbitrary values of sensitivity parameters. In contrast, our sensitivity
parameters are informed by the data. In other words, we do not need to consider the entire
range of values α∗ ∈ (0, 1] and β ∈ [−1, 1], instead we can consider the narrower range of
values consistent with the observed data. This will typically lead to a more meaningful
and interpretable sensitivity analysis.
3.3 Estimation & Inference
Next, we construct efficient nonparametric estimators for the parameter ψ∗(δ) and detail
their asymptotic properties, showing in particular how to construct confidence intervals.
Our approach to estimation makes use of semi- and non-parametric efficiency theory and
influence functions (Bickel et al. 1993; van der Laan & Robins 2003; Tsiatis 2006). Influence
functions are essential for a number of reasons. First, the influence function with the
smallest variance (called the efficient influence function) determines the efficiency bound
for estimating a parameter, thus giving a benchmark against which estimators can be
measured and indicating the difficulty of the problem. Second, influence functions can be
used to construct estimators with very favorable properties, such as double robustness or
general second-order bias. For this reason, influence function-based estimators can attain
fast parametric rates of convergence, even while allowing flexible nonparametric estimation
of complex high-dimensional nuisance functions.
First, we outline additional notation. We let Pn denote the empirical measure so that for
example sample averages can be written as n−1
∑
i f(Oi) = Pn(f) = Pn{f(X)}. Further,
for any arbitrary variable T ⊂ O, we let
φz(T ) =
1(Z = z)
piz(X)
{
T − E(T | X, Z = z)
}
+ E(T | X, Z = z)
denote the uncentered component of the efficient influence function for the parameter
E{φz(T )} = E{E(T | X, Z = z)}. Note that, in addition to z and T , the quantity
φz(T ) also depends on the variables (X, Z) as well as the nuisance functions piz(x) and
E(T | X = x, Z = z); for now we keep this dependence implicit for notational simplicity.
Similarly we let
φˆz(T ) =
1(Z = z)
pˆiz(X)
{
T − Eˆ(T | X, Z = z)
}
+ Eˆ(T | X, Z = z)
denote the estimated version of φz(T ), based on nuisance estimators pˆiz(X) and Eˆ(T |
X, Z = z). Note that we are largely agnostic about which particular methods are used
to construct these nuisance estimators, leaving this up to the analyst. Our theory allows
for either parametric or nonparametric estimators, with asymptotic normality and root-n
rates requiring certain convergence rate conditions, as detailed in Theorem 3. The functions
φz and φˆz will play an important role in constructing efficient estimators, analyzing their
asymptotic behavior, and computing confidence intervals.
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Before discussing our proposed estimators, we need to point out two regularity condi-
tions required for such estimators to be well-behaved. These conditions are required since
the bounds (α`, β`, βu) from the previous subsection are nonsmooth, i.e., α` and β` involve
maxima, and βu involves a minimum. In particular, without such conditions the parameter
ψ∗(δ) would not admit an influence function, and regular estimators would not exist. In-
formally, regular estimators are nicely behaved estimators whose asymptotic distribution is
invariant to small shifts in the data-generating process; for more details see van der Vaart
(2000), Tsiatis (2006), and Hirano & Porter (2012). The two regularity conditions we need
are as follows.
Condition 1. P{θ1(0 | X) = θ0(0 | X)} = 0.
Condition 2. P[µ1(X) ∈ {λ0(X), λ0(X)− λ1(X)}] = 0.
Conditions 1–2 are similar in spirit to so-called non-exceptional law conditions in opti-
mal treatment regime estimation (Robins 2004; van der Laan & Luedtke 2014). However,
our conditions may be more plausible since the quantities they restrict are not conditional
effects of the treatment A, which might reasonably be zero in practice.
Since under Assumptions 1–6 we have θz(0 | X) = P(A(z) = 0 | X), Condition 1 says
that there are almost no covariate strata in which the proportion of survivor-compliers
equals the proportion of units in the second stratum in Table 1 (i.e., compliers with respect
to selection, who take control when selected). In the ICU application this means that, for
almost all covariate strata, the proportion of patients who would always be admitted to the
ICU regardless of bed availability, but whose wait time would depend on availability (i.e.,
survivor-compliers), cannot equal the proportion of patients who would only be admitted
to the ICU with more beds available, and who would wait more than 4 hours if admitted.
This appears to be a plausible assumption in the ICU application; it would be surprising
if these particular strata happened to be exactly the same size.
Condition 2 is similar, though perhaps slightly less intuitive. Since under Assumptions
1–6 we have µz(X) = E(Y (z) = 1 | X, S(z) = 1)λz(X) and λz(X) = P(S(z) = 1 | X),
Condition 2 says that there are almost no covariate strata in which the mean outcome
under treatment for those selected under encouragement from the IV equals either (a)
the ratio P(S(z=0) = 1 | X)/P(S(z=1) = 1 | X) of those who would be selected under no
encouragement versus encouragement, or (b) this ratio minus one. Note that we must have
λ1(X) ≥ λ0(X) under monotonicity, so the only way the latter part of Condition 2 could
be violated is if for some non-negligible strata there are only always- and never-takers with
respect to selection, and in these exact strata the outcome for the always-takers happens to
be always zero. As with Condition 1, this is a somewhat contrived scenario that we would
generally not expect to encounter in practice.
Now we are ready to present our proposed estimator for ψ∗(δ), which is based on
estimates of the bounds on α and β. Specifically we let
αˆ` = Pn
(
1
{
θˆ0(0 | X) > θˆ1(0 | X)
}[
φˆ1{1(A 6= 0)} − φˆ0{1(A 6= 0)}
])
αˆu = Pn
[
φˆ1
{
1(A = 1)
}
− φˆ0
{
1(A = 1)
}]
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βˆ` = Pn
(
1
{
µˆ1(X)
λˆ1(X)− λˆ0(X)
> 1
}[
φˆ1{S(Y − 1)} − φˆ0(S)
]
− φˆ0(SY )
)/
Pn
{
φˆ0(S)
}
βˆu = Pn
[
1
{
µˆ1(X)
λˆ0(X)
> 1
}{
φˆ0(S)− φˆ1(SY )
}
+ φˆ1(SY )− φˆ0(SY )
]/
Pn
{
φˆ0(S)
}
denote efficient influence-function-based estimators of the bounds on (α, β), and then the
corresponding estimator of ψ∗(δ) is given by
ψ̂∗(δ) =
{
δ2βˆu + (1− δ2)βˆ`
δ1αˆu + (1− δ1)αˆ`
}
Pn
{
φˆ0(S)
}
.
In the Appendix we show that this estimator solves an estimating equation based on the
efficient influence function for ψ∗(δ); this is a standard technique for constructing efficient
estimators.
The next theorem gives conditions under which our proposed estimator is asymptotically
normal and efficient in a nonparametric model, which puts no constraints on the probability
distribution P (other than, at most, nonparametric smoothness, sparsity, or other structural
constraints). To ease notation we let θza = θz(a | x) and generally suppress the dependence
of the nuisance functions on X. We also let ‖f‖2 = ∫ f(x)2 dP(x) denote the squared
L2(P) norm.
Theorem 3. Along with Assumptions 1–6 and Conditions 1–2, assume
1. {ψ̂∗(δ), ηˆ} p→ {ψ∗(δ),η} for true value η = (piz, θza, λz, µz).
2. The influence functions ϕ(η) = (ϕ
(α)
` , ϕ
(α)
u , ϕ
(β)
` , ϕ
(β)
u ) (as defined in the Appendix)
and their estimates ϕ(ηˆ) fall in a Donsker class with probability one as n→∞, and
are estimated consistently in the sense that ‖ϕ(η)−ϕ(ηˆ)‖2 = oP(1).
3. ‖pˆi1 − pi1‖
(
maxz,a ‖θˆza − θza‖+ maxz ‖λˆz − λz‖+ maxz ‖µˆz − µz‖
)
= oP(1/
√
n).
4. ‖ηˆj−ηj‖
√
P(|ηj| < |ηˆj − ηj|) = oP(1/
√
n) for ηj ∈ {θ10− θ00, µ1− (λ1−λ0), µ1−λ0}.
Then √
n
{
ψ̂∗(δ)− ψ∗(δ)
}
 N
(
0, var
[
ϕ(β)(δ2)− ψ∗(δ)ϕ(α)(δ1)
E{ϕ(α)(δ1)}
])
where
ϕ(α)(δ1) = δ1ϕ
(α)
u + (1− δ1)ϕ(α)` , ϕ(β)(δ2) = δ2ϕ(β)u + (1− δ2)ϕ(β)`
for (ϕ
(α)
` , ϕ
(α)
u , ϕ
(β)
` , ϕ
(β)
u ) the efficient influence functions as defined in the Appendix.
Theorem 3 is critically important. It shows that our proposed estimator is
√
n consistent
and asymptotically normal even if the nuisance functions η are estimated at slower than
parametric
√
n rates, as long as they attain the n1/4-type rates described in Conditions 3–4
of Theorem 3. Importantly, such n1/4 rates are attainable under sparsity, smoothness, or
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other nonparametric structural constraints, whereas the
√
n rates required by maximum-
likelihood-type estimators necessitate the use of correct parametric models (which can be
difficult if not impossible to specify even in the presence of a few continuous covariates).
Further, 95% confidence intervals can be easily constructed as ψ̂∗(δ)± 1.96σˆ(δ)/√n, using
empirical estimates of the asymptotic variance σˆ2 = Pn{(ϕˆ(β)− ψ̂∗ϕˆ(α))2}/{Pn(ϕˆ(α))}2 (the
dependence on δ is suppressed for notational simplicity). This does not require any extra
estimation or model-fitting since the estimated influence functions ϕˆ are already computed
to construct the estimator ψ̂∗. Condition 2 of Theorem 3 puts a mild restriction on the
complexity of the nuisance estimators we use, however this can be completely avoided by
sample splitting (Zheng & van der Laan 2010). In summary, Theorem 3 allows for efficient√
n-rate estimation and valid inference (e.g., confidence intervals), even though our analysis
is nonparametric and can incorporate complex machine learning methods.
3.4 Bounding the Effect of ICU Wait Times
We estimate the bounds for SCATE ψ both with and without covariates to understand how
covariate information might narrow the bounds. Without using covariates, the upper and
lower bounds on the survivor-complier proportion α are 0 and 0.08, respectively. Thus the
percentage of patients that would wait less than four hours to gain access to the ICU due
to bed availability is between 0 and 8%. The upper and lower bounds for β are -0.19 and
0.06. As such, bed availability among those always admitted to the ICU in less than four
hours may have reduced mortality by 19% or increased mortality by 6%. The corresponding
bounds for the SCATE ψ are -1 and 1 and thus are uninformative.
We next estimate these bounds exploiting covariate information to weaken identifying
assumptions and gain more efficiency. We model the covariate relationships (i.e., nuisance
functions η) flexibly using Super Learner (van der Laan & Rose 2011), combining logistic
regression, generalized additive models, lasso, and multivariate adaptive regression splines.
With covariates, the bounds on α are 0.01 and 0.07, and the bounds on β are -0.14 and
0.05. The bounds for SCATE ψ remain -1 and 1. Thus although incorporating covariate
information sharpens the bounds on α and β considerably (reducing length by 23% for
α and 22% for β), it does not sharpen the bounds for the ratio ψ. Next, we conduct
a sensitivity analysis where we estimate ψ using the estimated bounds on α and β as
sensitivity parameters. This analysis creates a grid of possible ψ estimates, and for each of
these ψ estimates, we construct point-wise confidence intervals. The results are contained
in Figure 3. These results are substantially more informative than the bounds on ψ alone.
We observe that the preponderance of estimates for ψ indicate that shorter waiting times
for the ICU reduces mortality. The sensitivity plot does not rule out the possibility that
shorter waiting times increase mortality. However, the bounds clearly favor the possibility
that prompt ICU care reduces mortality. Moreover, analyses of these same data using an
IV analysis found that ICU care generally lowers mortality rates (Keele et al. 2016). While
that estimate is based on a different sub-population, finding that ICU care is generally
beneficial in conjunction with our analysis provides further evidence that prompt ICU care
is beneficial for patients.
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Sensitivity plot for ψ estimates
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Figure 3: Sensitivity plot for the effect of ICU waiting time on mortality. Points in the
rejection region do not include zero in a 95% point-wise confidence interval.
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4 Simulation
Finally, we conduct a simulation to better understand under what conditions the bounds
will be informative. Here, we simulate data from the true causal model and calculate the
bounds while varying the magnitude of the true values for α and ψ. The sample size for each
simulation is 1000, and the simulations were repeated 1000 times for each combination of
the true α and ψ parameters. In all scenarios, the instrumental variable, Z, was generated
as a Bernoulli random variable with the probability of success set to 0.5. We simulated
principal strata membership probabilistically, with the probability of being in the complier-
survivor strata set to α, and the probability of being in the other five principal strata as
(1−α)/5. Within the complier-survivor stratum, Y is a draw from a binomial distribution
with probability (0.5 − ψ)/2, and is a draw from a binomial distribution with probability
0.5 for the over five principal strata. We calculated the bounds for ψ using values of 0
to 1 for α and -1 to 1 for ψ in increments of 0.01. For each simulation, we recorded the
length of the bounds and whether the sign for the lower and upper bound agree. These
two quantities capture how much information is in the bounds as a function of whether the
instrument encourages A = 1 and the magnitude of the true causal effect. When A is not
highly affected by the instrument and when the true causal effect is small the bounds are
unlikely to be informative. However, of greater interest is the point at which the bounds
can at least be informative about the sign of the true causal effect.
In the simulation, we also studied how covariates can narrow the bounds. In the first
set of simulations, we did not condition on covariates. In two additional simulations,
we generated S as a function of two Normally distributed covariates. In one simulation,
the covariates were more weakly informative for S as both were correlated with S at
approximately 0.50; in the second set, the two covariates were more informative as both
were correlated with S at approximately 0.85.
We summarize the results from the simulations in Figure 4. First, we examine the length
of the bounds. In this plot, we observe that the overall length of the bounds is primarily
a function of the value of α. That is, the bounds will be at their maximum length of 2
when α is approximately 0.40 or less regardless of the size of ψ. Next, we plot when the
bounds are informative as to the sign of the true causal effect. Here, the results depend
on the magnitude of both α and ψ. We observe that when the ψ is larger and α is less
than 0.40, the bounds may be informative about the sign of the causal effect, but given the
information in the two other panels the bounds are likely to be quite wide. However, once
α is larger than 0.40 the information about the sign of the causal effect depends directly on
the magnitude of ψ. Moreover, for larger values of α the bounds can be highly informative.
For example, if ψ is 0.10, and α is 0.65, the bounds are 0.04 and 0.26. If α increases to
0.75 and ψ remains 0.10, the bounds narrow to 0.04 and 0.18. If α remains 0.65, but ψ
increases to 0.20, the bounds actually widen to 0.06 and 0.42.
Figure 4 also shows results from the simulations where covariates were used to construct
the bounds. First, we observe that even with the covariates that are more weakly predictive
of S, the width of the bounds decreases and the region in which the sign of the bounds is
informative is much larger. Across all the values for α and ψ in the simulations, the average
length of the bounds without covariates was 0.91. With the weakly predictive covariates,
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Figure 4: Estimated bounds using simulated data from a known causal model, across 1000 simulation
for each α and ψ value. Grey areas indicate that bounds are uninformative. “Weak covariates” refers to
the case where covariates weakly predict S = 1. “Strong covariates” refers to the case where covariates
strongly predict S = 1.
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the average length of the bounds decreases to 0.58, and with the strongly predictive co-
variates, the average length of the bounds was 0.06. The simulations clearly indicate that
the bounds can be highly informative, but it is essential that either values of α are fairly
high or that the covariates be at least weakly predictive of S. In the ICU data, we found
α to be much lower, and the covariates were not strongly associated with ICU admission.
In these situations, use of the sensitivity analysis will likely be more informative.
5 Discussion
One critical clinical question of practical importance given limited health care resources is
whether delayed admission to the ICU is beneficial. Answers to this question are elusive
since the population referred to critical care tends to be sicker than the population that
remains on a general hospital ward, and wait times for the ICU are censored for any
patients not admitted to the ICU. While instruments can allow for causal inference in
the presence of unobserved confounders, we proved that IV methods do not identify the
usual causal estimand of interest in our application. We demonstrated that while point-
identification is not possible without further assumptions, partial identification is possible.
These bounds can incorporate covariate information in a flexible and data-adaptive way.
Moreover, our use of influence function-based methods allows for efficient estimation and
inference, even when modeling covariate relationships very flexibly using machine learning
tools. Despite their usefulness, influence-function-based approaches seem not to have been
used previously in partial identification problems, perhaps due to the relative complexity
and nonsmoothness issues discussed in Section 3.3. Simulations show that our bounds can
be highly informative, but the instrument must encourage a relatively large portion of the
population to be survivor-compliers, or else covariates must strongly predict selection. That
is, to produce bounds that are highly informative about the true causal effect, covariate
selection is critical unless the effect of the instrument is very strong. Our results serve as
an important guide for data collection, by indicating to investigators the importance of
measuring covariates that predict selection. For example, one could utilize pilot study data
to identify such covariates. Nonetheless our data-driven sensitivity analysis approach can
provide a useful picture even when bounds are wide, as observed in our ICU application.
As is often the case with studies based on partial identification, we cannot offer the
certainty of a point estimate and confidence interval. However, we think our proposed
methods offer important evidence about the clinical question of ICU waiting times. While
the bounds on the causal effect of waiting times were uninformative about the true causal
effect, use of a sensitivity analysis did provide evidence that waiting less than four hours
to receive critical care reduces mortality. While we cannot rule out causal effects of the
opposite sign, we argue that, taken with other analyses, there is some evidence that reducing
waiting times for the ICU is a clinical goal worth pursuing. Although for some causal
questions the best available evidence may not take the form of a single point estimate, we
have showed that advances in nonparametric efficiency theory and data-adaptive regression
methods can still play a crucial role. We look forward to more future developments in partial
identification problems with interesting study designs and complex confounding.
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7 Appendix
7.1 Proof of Proposition 1
To prove non-identifiability of ψ, we only need to find an observed data distribution that
can yield different values of the parameter ψ. We give a simple example here, but non-
identifiability also follows from the fact that the bounds in Theorem 1 are sharp. Suppose
there are no covariates (X = ∅) and there are only two principal strata, indexed by variable
C ∼ Bernoulli(0.5) with
C = 1 ⇐⇒ (S(z=0) = S(z=1) = 1, A(z=1) > A(z=0)),
C = 0 ⇐⇒ (S(z=0) < S(z=1), A(z=1) = 1).
This means there are only treatment-compliers and selection-compliers who take treatment.
By unconfoundedness, P(Z = z, S = s, A = a) = P(S(z) = s, A(z) = a) = 1(z = a = 1)/2.
Also suppose Y is binary and Y (z=0) = 0 with probability one. Then P(Y = 1 | A, S, Z) = 0
except when A = S = Z = 1, in which case
P(Y = 1 | A = S = Z = 1) =
1∑
c=0
P(Y (z=1) = 1 | C = c)P(C = c) = 0.5(ψ + ξ)
where ξ = P(Y (z=1) = 1 | C = 0). Thus any choices of (ψ, ξ) with the same sum (ψ + ξ)
would yield the same observed data distribution; for example, both (ψ, ξ) = (1, 0) and
(ψ, ξ) = (0, 1) give P(Y = 1 | A = S = Z = 1) = 0.5.
7.2 Proof of Proposition 2
We have
β = E(Y (z=1) − Y (z=0) | S(z=1) = S(z=0) = 1)
= E(Y (z=1,A(z=1)) − Y (z=0,A(z=0)) | S(z=1) = S(z=0) = 1)
= E(Y (A(z=1)) − Y (A(z=0)) | S(z=1) = S(z=0) = 1)
= E{(Y (a=1) − Y (a=0))1(A(z=1) > A(z=0)) | S(z=1) = S(z=0) = 1}
= E(Y (a=1) − Y (a=0) | S(z=1) = S(z=0) = 1, A(z=1) > A(z=0))
× P(A(z=1) > A(z=0) | S(z=1) = S(z=0) = 1)
= ψα/P(S(z=1) = S(z=0) = 1)
where the first equality follows by definition, the second by the fact that Y (z) = Y (z,A
(z))
from Assumption 1 (consistency), the second by Assumption 5 (exclusion), the third by
Assumption 6 (monotonicity), the fourth by iterated expectation and Assumption 3 (in-
strumentation), and the last by definition. Rearranging gives the desired result.
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7.3 Proof of Theorem 1
To ease notation, in this section all potential outcomes are with respect to interventions on
the instrument Z (not treatment A), so that we can write Y 1 = Y (z=1), for example.
7.3.1 Bounds on α
For the upper bound on α, clearly we have
P(A1 > A0 | X) ≤ P(A1 > A0 | X) + P(A1 > S0 | X).
Now note that
{A1 > A0} ∪ {A1 > S0} = [{A1 > A0} ∪ {A1 > S0} ∪ {A1 = A0 = 1}] ∩ {A1 = A0 = 1}
= {A1 = 1} ∩ {A1 = A0 = 1} = {A1 = 1} ∩ {A0 = 1}
where the first equality follows from simple logic, the second by definition of {A1 = 1}, and
the third by monotonicity. Therefore
P(A1 > A0 | X) ≤ P(A1 = 1 | X)− P(A0 = 1 | X)
= P(A = 1 | X, Z = 1)− P(A = 1 | X, Z = 0)
where the equality follows by consistency, positivity, and unconfoundedness. Hence
α = E{P(A1 > A0 | X)}
≤ E{P(A = 1 | X, Z = 1)− P(A = 1 | X, Z = 0)} = αu.
For the lower bound on α, we similarly have
P(A1 > A0 | X) ≥ {P(A1 > A0 | X)− P(S0 = A1 = 0 | X)}+.
Now note that the right-hand side (before taking the positive part) is
P(A1 > A0 | X) + P(A0 = A1 = 0 | X)− P(A0 = A1 = 0 | X)− P(S0 = A1 = 0 | X)
= P(A0 = 0 | X)− P(A1 = 0 | X)
= P(A = 0 | X, Z = 0)− P(A = 0 | X, Z = 1)
where the first equality follows by the facts that {A1 > A0} ∪ {A0 = A1 = 0} = {A0 = 0}
since A is binary and
{A0 = A1 = 0} ∪ {S0 = A1 = 0} = {A0 = 0}
by monotonicity, and the second follows by consistency, positivity, and unconfoundedness.
Hence
α = E{P(A1 > A0 | X)} ≥ E[{P(A = 0 | X, Z = 0)− P(A = 0 | X, Z = 1)}+] = α`.
2
7.3.2 Bounds on β
Before deriving the bounds on β, we first give a useful lemma.
Lemma 1. Suppose H = pF + qG, where (H,F,G) are cumulative distribution functions
for non-negative random variables (XH , XF , XG), and p > 0 and q > 0 are weights with
p + q = 1. Suppose the parent distribution H and weights p and q are known, but the
component distributions F and G are unknown. Then sharp bounds on the mean under F
are given by∫
(p−H) ∨ 0
p
=
∫
(1− F ∗` ) ≤
∫
XF dF ≤
∫
(1− F ∗u ) =
∫
(1−H) ∧ p
p
for the bounding distributions F ∗` =
(
H
p
)
∧ 1 and F ∗u =
(
H−q
p
)
∨ 0.
Proof. Since the random variables associated with the distributions (H,F,G) are non-
negative, we can write expectations as integrated survival functions, as in
∫
XF dF =∫
(1− F ). Therefore to show that the means under F ∗` and F ∗u are valid bounds, we must
show that
∫
F ≤ ∫ F ∗` and ∫ F ∗u ≤ ∫ F .
For F ∗` note that ∫
(F ∗` − F ) =
∫ (
H
p
)
∧ 1−
∫ (
H − qG
p
)
=
∫
H>p
(1− F ) +
∫
H≤p
qG
p
≥ 0
where the last inequality follows since 1 ≥ F = (H − qG)/p and qG/p ≥ 0, because
(F,G, p, q) are all probabilities bounded between zero and one. Similarly, for F ∗u we have∫
(F − F ∗u ) =
∫ (
H − qG
p
)
−
∫ (
H − q
p
)
∨ 0
=
∫
H>q
q(1−G)
p
+
∫
H≤q
F ≥ 0
where again the last inequality follows since (F,G, p, q) are all in [0, 1].
To show sharpness, we must give component distributions F and G that attain the bounds
and can be mixed using (p, q) to form any known H, i.e., we can show that pF ∗u + qG
∗
` = H
for G∗` = (H/q) ∧ 1 (for F ∗` we can simply reverse the role of F and G). This follows since
pF ∗u + qG
∗
` = p
{(
H − q
p
)
∨ 0
}
+ q
{(
H
q
)
∧ 1
}
=
p
(
H−q
p
)
+ q if H > q
0 + q
(
H
q
)
if H ≤ q
= H.
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First note that
β = E{E(Y 1 − Y 0 | X, S0 = S1 = 1)P(S0 = S1 = 1 | X)}/P(S0 = S1 = 1)
= E{E(Y 1 − Y 0 | X, S0 = 1)P(S0 = 1 | X)}/P(S0 = 1)
=
E[{E(Y 1 | X, S0 = 1)− E(Y | X, S = 1, Z = 0)}P(S = 1 | X, Z = 0)]
E{P(S = 1 | X, Z = 0)}
where the first equality follows by definition (and iterated expectation), the second by
monotonicity, and the third by consistency, positivity, and unconfoundedness.
Now we use Lemma 1 to construct bounds for E(Y 1 | X, S0 = 1). Let
H = P(Y 1 ≤ y | X, S1 = 1)
F = P(Y 1 ≤ y | X, S0 = 1)
p = P(S0 = 1 | X, S1 = 1)
so that E(Y 1 | X, S0 = 1) = ∫ (1−F ) = 1−F (0) = F (0) since Y is binary. Also note that
H = P(Y ≤ y | X, S = 1, Z = 1)
p =
P(S0 = 1 | X)
P(S1 = 1 | X) =
P(S = 1 | X, Z = 0)
P(S = 1 | X, Z = 1) =
λ0(X)
λ1(X)
where the equality for H and the second equality for p use consistency, positivity, and
unconfoundedness, and the first equality for p uses monotonicity.
Therefore Lemma 1 gives
E(Y 1 | X, S0 = 1) ≥
∫
(p−H) ∨ 0
p
=
∫
(H − q) ∨ 0
p
= {µ1(X)− λ1(X) + λ0(X)}+/λ0(X)
where the second equality comes from rearranging and using the fact that Y is binary so
that
∫
H = H(0) = E(Y | X, S = 1, Z = 1). Similarly we have
E(Y 1 | X, S0 = 1) ≤
∫
(1−H) ∧ p
p
= {µ1(X) ∧ λ0(X)}/λ0(X).
Therefore, using the definitions from the main text and plugging in the results from Lemma
1 gives
β = E{E(Y 1 | X, S0 = 1)λ0(X)− µ0(X)}/E{λ0(X)}
≥ E{{µ1(X)− λ1(X) + λ0(X)}+ − µ0(X)}/E{λ0(X)} = β`
and similarly
β ≤ E{{µ1(X) ∧ λ0(X)} − µ0(X)}/E{λ0(X)} = βu
4
7.4 Proof of Theorem 2
Theorem 2 follows from the bounds on α and β given in Theorem 1, along with the expres-
sion for ψ given in Proposition 2. In particular, note that the bounds on β imply
β`E{λ0(X)} ≤ βE{λ0(X)} ≤ βuE{λ0(X)}
where we used the fact that
P(S0 = S1 = 1) = P(S0 = 1) = E{P(S = 1 | X, Z = 0)} > 0
where the first equality comes from monotonicity, and the second from consistency, posi-
tivity, and unconfoundedness.
Now we consider three cases depending on whether the above bounds on the numerator
are positive or negative. All three results follow from the fact that c > 0 and 0 < α` ≤
α ≤ αu ≤ 1, we have c/αu ≤ c/α` and −c/αu ≥ −c/α`. If both numerator bounds are
non-negative so that 0 ≤ β` then
β`E{λ0(X)}
αu
≤ β`E{λ0(X)}
α
≤ ψ ≤ βuE{λ0(X)}
α
≤ βuE{λ0(X)}
α`
.
Similarly if both numerator bounds are zero or negative so that βu ≤ 0 then
β`E{λ0(X)}
α`
≤ β`E{λ0(X)}
α
≤ ψ ≤ βuE{λ0(X)}
α
≤ βuE{λ0(X)}
αu
.
Finally if the lower numerator bound is non-positive and the upper is non-negative so that
β` ≤ 0 ≤ βu then it follows that
β`E{λ0(X)}
α`
≤ β`E{λ0(X)}
α
≤ ψ ≤ βuE{λ0(X)}
α
≤ βuE{λ0(X)}
α`
.
This yields the desired result.
7.5 Proof of identification when X predicts S
Here we consider the case where the covariates X can perfectly predict selection S, in the
sense that there exists some mapping g : X 7→ {0, 1} such that S = g(X) wp1. We will
show that in this case the bounds collapse to a single point, and the SCATE ψ is identified.
First consider the bounds on β. Note that if S = g(X) then
λZ(X) = E(S | X, Z) = E{g(X) | X, Z} = g(X) = S.
Therefore λ0(X)− λ1(X) = S − S = 0 and the lower bound on β is given by
β` =
E[{µ1(X) + λ0(X)− λ1(X)}+ − µ0(X)]
E{λ0(X)} =
E{µ1(X)− µ0(X)}
E{λ0(X)} .
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Similarly
µ1(X) ∧ λ0(X) = µ1(X) ∧ S = µ1(X)
because
µZ(X) = E(SY | X, Z) = E{g(X)Y | X, Z} = g(X)E(Y | X, Z) = SE(Y | X, Z) ≤ S
since Y ∈ [0, 1]. Therefore the upper bound on β is given by
βu =
E[{µ1(X) ∧ λ0(X)} − µ0(X)]
E{λ0(X)} =
E{µ1(X)− µ0(X)}
E{λ0(X)}
and thus matches the lower bound, so that β is point-identified.
Now consider the bounds on α. Recall θz(a | X) = P(Az = a | X) based on the identifying
assumptions. If we also have S = g(X) then
θz(a | X) = P{A = a | X, g(X), Z = z} = P(A = a | X, S, Z = z)
= P(Az = a | X, Sz)
so that S = g(X) implies Az ⊥⊥ Sz | X. Hence
θz(a | X) = P(Az = a | X, Sz = 1).
But Az ∈ {0, 1} when Sz = 1, so that
θ1(1 | X)− θ0(1 | X) = {1− θ1(0 | X)} − {1− θ0(0 | X)}
and therefore the lower and upper bounds α` and αu are equal, so that α is point-identified.
7.6 Proof of Theorem 3
7.6.1 Efficient influence function for ψ∗(δ)
First we prove two lemmas describing efficient influence functions for bounds on (α, β).
Lemma 2. Under Condition 1 the efficient influence functions for the bounds (α`, αu) on
the survivor-complier proportion are given by ϕ
(α)
`/u − α`/u for
ϕ
(α)
` = 1
{
θ0(0 | X) > θ1(0 | X)
}[
φ1{1(A 6= 0)} − φ0{1(A 6= 0)}
]
ϕ(α)u = φ1{1(A = 1)} − φ0{1(A = 1)}.
Proof. The fact that ϕ
(α)
u − αu is the efficient influence function for αu is well-known,
since αu is mathematically equivalent to the X-adjusted average treatment effect of Z on
1(A = 1). This result has been previously discussed by Robins et al. (1994), Hahn (1998),
and Scharfstein et al. (1999) among others. Thus we need only consider the parameter α`.
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The lower bound α` is more delicate, in particular since it is a non-smooth function of the
nuisance functions θz(0 | X). Nonetheless we can adapt a result from the optimal treatment
regime literature to give conditions under which it is pathwise differentiable (i.e., has an
influence function) and regularly estimable at
√
n rates.
Letting γ1(X) = θ1(0 | X)− θ0(0 | X), note that
α` = E{γ1(X)+} = E[γ1(X)1{γ1(X) > 0}].
Now we can use the same logic as in Theorem 2 and Lemma 2 of van der Laan & Luedtke
(2014) to show that the influence function for α` under Condition 1 is the same as that
treating the indicator 1{γ1(X) > 0} in α` as known. Hence under Condition 1 the non-
smoothness of α` is inconsequential.
Specifically, letting {P :  ∈ R} denote a smooth parametric submodel passing through P
at  = 0 (e.g., dP = (1 + h)dP for bounded mean-zero h = h(O)), we have (suppressing
the subscript on γ1 for simplicity)
α`(P)− α`(P) =
∫
γ1(γ > 0) dP −
∫
γ1(γ > 0) dP
=
∫
1(γ > 0)(γ dP − γ dP) +
∫
γ
{
1(γ > 0)− 1(γ > 0)
}
dP.
The first term, after dividing by  and letting → 0, is the pathwise derivative for the case
where the indicator 1(γ1 > 0) is known. This corresponds to the influence function ϕ
(α)
`
given in the statement of Lemma 2, which follows by standard chain rule arguments as in
Hahn (1998) and elsewhere. Now, again following the same logic as in Lemma 2 of van der
Laan & Luedtke (2014), we will show that the second term is o(||) under Condition 1, and
so does not contribute to the influence function.
In absolute value, the second term is bounded above by∫
|γ|
∣∣∣1(γ > 0)− 1(γ > 0)∣∣∣ dP ≤ ∫ |γ|1(|γ| < |γ − γ|) dP
≤
∫
(|γ|+ C||)1(|γ| < C||) dP . ||(1 + ||)
∫
1(|γ| < C||) dP
= ||(1 + ||)P(0 < |γ| < C||) = o(||)
where the second bound follows since |γ| = |γ− γ| − |γ| whenever γ and γ have different
signs, the third and the fourth by the submodel construction and boundedness of γ, and
the fifth by Condition 1. Hence this term does not contribute to the pathwise derivative,
and the influence function for α` is the same as if the indicator 1(γ1 > 0) was known.
Lemma 3. Under Condition 2 the efficient influence functions for the bounds (β`, βu) on
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the survivor intention-to-treat effect are given by E{φ0(S)}−1{ϕ(β)`/u − β`/uφ0(S)} for
ϕ
(β)
` = 1
{
µ1(X)
λ1(X)− λ0(X) > 1
}[
φ1{S(Y − 1)} − φ0(S)
]
− φ0(SY )
ϕ(β)u = 1
{
µ1(X)
λ0(X)
> 1
}{
φ0(S)− φ1(SY )
}
+ φ1(SY )− φ0(SY ).
Proof. This proof is similar to that of Lemma 2. The efficient influence function for the
denominator E{λ0(X)} of the bounds on β is straightforward, as this parameter is mathe-
matically equivalent to the marginal mean of an outcome missing at random (Robins et al.
1994; Hahn 1998; Scharfstein et al. 1999). Specifically the influence function is given by
φ0(S) − E{λ0(X)}. The same goes for the subtracted numerator term E{µ0(X)}, which
similarly has influence function φ0(SY )− E{µ0(X)}.
Now consider the non-smooth terms in the numerators. Letting γ2(X) = µ1(X) + λ0(X)−
λ1(X), we have that the non-smooth term in the numerator of β` is
E{γ2(X)+} = E[γ2(X)1{γ2(X) > 0}]
and so can be analyzed exactly as in Lemma 2, except replacing Condition 1 with
P{µ1(X) = λ1(X)− λ0(X)} = 0
as in Condition 2, to ensure that γ2 = µ1 + λ0 − λ1 does not have a point mass at zero.
Therefore the influence function for this parameter is the same as that treating the indica-
tor 1(µ1 > λ1 − λ0) as known, which is given in the statement of Lemma 3.
Similarly, now letting γ3(X) = µ1(X) − λ0(X), the non-smooth term in the numerator of
βu is given by
E{µ1(X) ∧ λ0(X)} = E[µ1(X)1{λ0(X) ≥ µ1(X)}+ λ0(X)1{µ1(X) > λ0(X)}]
= E[µ1(X) + {λ0(X)− µ1(X)}1{µ1(X) > λ0(X)}]
= E[µ1(X)− γ3(X)1{γ3(X) > 0}].
Again the first term above can be analyzed with standard techniques, as it is mathematically
equivalent to the marginal mean of an outcome missing at random. The second term is
exactly the same as in the previous two examples in Lemma 2 and the first part of this
Lemma 3. The second part of Condition 2, that
P{µ1(X) = λ0(X)} = 0,
again ensures that γ3 = µ1−λ0 does not have a point mass at zero. Therefore the influence
function is the same as that treating the indicator 1(γ3 > 0) = 1(µ1 > λ0) as known.
Now that we have the influence functions for each the components making up the lower
and upper bounds of β, the final result of Lemma 3 follows after combining these influence
functions using the chain rule, and rearranging.
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That the efficient influence function of ψ∗(δ) is given as in Theorem 3, i.e.,
ϕ(η) = {ϕ(β)(δ2)− ψ∗(δ)ϕ(α)(δ1)}/E{ϕ(α)(δ1)}
with ϕ(α)(δ1) = δ1ϕ
(α)
u +(1−δ1)ϕ(α)` and ϕ(β)(δ2) = δ2ϕ(β)u +(1−δ2)ϕ(β)` now follows directly
from Lemmas 2–3 together with the chain rule.
7.6.2 Asymptotic results for ψ̂∗(δ)
To ease notation, in this subsection we drop the dependence of all quantities on δ, and
write
ψˆ = ψ̂∗(δ) , ϕα = ϕ(α)(δ1) , ϕβ = ϕ(β)(δ2).
By definition, the estimator ψˆ solves the efficient influence function estimating equation,
i.e., ψˆ = Pn{ϕβ(ηˆ)}/Pn{ϕα(ηˆ)}. Therefore we have
ψˆ − ψ = Pn{ϕβ(ηˆ)}
Pn{ϕα(ηˆ)} −
P{ϕβ(η)}
P{ϕα(η)} =
P{ϕα(η)}Pn{ϕβ(ηˆ)} − P{ϕβ(η)}Pn{ϕα(ηˆ)}
Pn{ϕα(ηˆ)}P{ϕα(η)}
=
P{ϕα(η)}[Pn{ϕβ(ηˆ)} − P{ϕβ(η)}]− P{ϕβ(η)}[Pn{ϕα(ηˆ)} − P{ϕα(η)}]
Pn{ϕα(ηˆ)}P{ϕα(η)}
= Pn{ϕα(ηˆ)}−1
([
Pn{ϕβ(ηˆ)} − P{ϕβ(η)}
]
− ψ
[
Pn{ϕα(ηˆ)} − P{ϕα(η)}
])
Now we will analyze the two terms in parentheses. For the β part we have
Pn{ϕβ(ηˆ)} − P{ϕβ(η)} = (Pn − P){ϕβ(ηˆ)− ϕβ(η)}+ (Pn − P)ϕβ(η)− P{ϕβ(ηˆ)− ϕβ(η)}
The first term is a centered empirical process and is oP(1/
√
n) by, for example, Lemma 19.24
in van der Vaart (2000) since ϕβ lies in a Donsker class and ‖ϕβ(ηˆ)− ϕβ(η)‖2 = oP(1) by
the assumptions of Theorem 3. With sample splitting this term will be oP(1/
√
n) under
only the consistency assumption, without requiring any Donsker conditions. The second
term is asymptotically normal after scaling by
√
n, by the central limit theorem.
The third term captures the effect of nuisance estimation, and for it we have
P{ϕβ(ηˆ)− ϕβ(η)} = δ2P{ϕβ,u(ηˆ)− ϕβ,u(η)}+ (1− δ2)P{ϕβ,`(ηˆ)− ϕβ,`(η)}.
First consider the first term on the right hand side, referring to the definition of ϕβ in
Lemma 3. Repeated iterated expectation shows that
P{φˆz(SY )− φz(SY )} . ‖pˆi1 − pi1‖‖µˆz − µz‖.
Let γ3 = µ1 − λ0 as before and also let φ = φ0(S) − φ1(SY ). Then the same arguments,
combined with the result from Theorem 3 of van der Laan & Luedtke (2014), show that
P{1(γˆ3 > 0)φˆ− 1(γ3 > 0)φ} = P{1(γˆ3 > 0)(φˆ− φ) + {1(γˆ3 > 0)− 1(γ3 > 0)}φ}
. ‖pˆi1 − pi1‖
(
‖µˆ1 − µ1‖+ ‖λˆ0 − λ0‖
)
+ ‖γˆ3 − γ3‖
√
P(γ3 < |γˆ3 − γ3|).
9
Therefore, combining the above results, we have that P{ϕβ,u(ηˆ) − ϕβ,u(η)} is bounded
above (up to constants) by
‖pˆi1 − pi1‖
(
max
z
‖µˆz − µz‖+ ‖λˆ0 − λ0‖
)
+ ‖γˆ3 − γ3‖
√
P(γ3 < |γˆ3 − γ3|)
and this is oP(1/
√
n) by Assumptions 3–4 of Theorem 3.
The same logic shows that, for γ2 = µ1 − (λ1 − λ0),
P{ϕβ,`(ηˆ)− ϕβ,`(η)} . ‖pˆi1 − pi1‖
(
max
z
‖λˆz − λz‖+ max
z
‖µˆz − µz‖
)
+ ‖γˆ2 − γ2‖
√
P(γ2 < |γˆ2 − γ2|),
and this is also oP(1/
√
n) by Assumptions 3–4 of Theorem 3.
Therefore P{ϕβ(ηˆ)− ϕβ(η)} = oP(1/
√
n), which implies
Pn{ϕβ(ηˆ)} − P{ϕβ(η)} = (Pn − P)ϕβ(η) + oP(1/
√
n).
Similarly for the α part of the earlier decomposition we have
Pn{ϕα(ηˆ)} − P{ϕα(η)} = (Pn − P){ϕα(ηˆ)− ϕα(η)}+ (Pn − P)ϕα(η)− P{ϕα(ηˆ)− ϕα(η)}
The first term is again centered empirical process and is oP(1/
√
n) since ϕα lies in a Donsker
class and ‖ϕα(ηˆ)−ϕα(η)‖2 = oP(1) by the assumptions of Theorem 3. The second term is
asymptotically normal after scaling by
√
n, by the central limit theorem.
As with the β part of the decomposition, we have
P{ϕα(ηˆ)− ϕα(η)} = δ1P{ϕα,u(ηˆ)− ϕα,u(η)}+ (1− δ1)P{ϕα,`(ηˆ)− ϕα,`(η)}.
Standard iterated expectation arguments show that
P{ϕα,u(ηˆ)− ϕα,u(η)} . ‖pˆi1 − pi1‖
(
max
z
‖θˆz1 − θz1‖
)
and this is oP(1/
√
n) by Assumptions 3–4 of Theorem 3. As with β, for γ1 = θ10 − θ00 we
have
P{ϕα,`(ηˆ)− ϕα,`(η)} . ‖pˆi1 − pi1‖
(
max
z
‖θˆz0 − θz0‖
)
+ ‖γˆ1 − γ1‖
√
P(γ1 < |γˆ1 − γ1|),
and this is also oP(1/
√
n) by Assumptions 3–4 of Theorem 3.
Therefore P{ϕα(ηˆ)− ϕα(η)} = oP(1/
√
n), which implies
Pn{ϕα(ηˆ)} − P{ϕα(η)} = (Pn − P)ϕα(η) + oP(1/
√
n).
Hence
ψˆ − ψ = Pn{ϕα(ηˆ)}−1
[
(Pn − P)
{
ϕβ(η)− ψϕα(η)
}]
+ oP(1/
√
n)
which yields the result of the theorem, after applying the continuous mapping theorem and
Slutsky’s theorem (noting that Pn{ϕα(ηˆ)} − P{ϕα(η)} = oP(1) by the above results).
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